Shareholders' Deficit (Tables)
|
12 Months Ended |
Dec. 31, 2020 |
|---|
| Equity [Abstract] |
|
| Schedule of redemption period |
| Redemption
Period |
|
Redemption
Percentage |
| 1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date. |
|
|
100% |
| 2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date. |
|
|
107% |
| 3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date. |
|
|
112% |
| 4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date. |
|
|
117% |
| 5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date. |
|
|
120% |
|
| Schedule of nonvested activity |
| |
|
Number of Non-vested Shares
|
|
|
Weighted Average Grant Date Fair Value |
|
| Non-vested, December 31, 2018 |
|
|
5,998,672 |
|
|
$ |
0.61 |
|
| Granted |
|
|
12,000,000 |
|
|
|
0.05 |
|
| Forfeited |
|
|
(323,373 |
) |
|
|
(0.59 |
) |
| Non-vested, December 31, 2019 |
|
|
17,675,299 |
|
|
|
0.23 |
|
| Granted |
|
|
7,450,000 |
|
|
|
0.04 |
|
| Shares vested |
|
|
(1,298,373 |
) |
|
|
(0.41 |
) |
| Non-vested, December 31, 2020 |
|
|
23,826,926 |
|
|
$ |
0.16 |
|
|
| Schedule of stock option activities |
| |
|
Number of Options |
|
|
Weighted Average Exercise
Price |
|
|
Weighted Average Remaining Contractual Term
(Years) |
|
|
Aggregate Intrinsic
Value |
|
| Balance Outstanding, December 31, 2018 |
|
|
11,445,698 |
|
|
$ |
0.30 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
(3,000,000 |
) |
|
|
0.03 |
|
|
|
|
|
|
|
|
|
| Balance Outstanding, December 31, 2019 |
|
|
8,445,698 |
|
|
|
0.40 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
| Balance Outstanding, December 31, 2020 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
5.10 |
|
|
$ |
48,000 |
|
| Exercisable, December 31, 2020 |
|
|
8,445,698 |
|
|
$ |
0.40 |
|
|
|
5.10 |
|
|
$ |
48,000 |
|
|
| Schedule of warrant activities |
| |
|
Number of Warrants |
|
|
Weighted Average Exercise
Price |
|
|
Weighted Average Remaining Contractual Term
(Years) |
|
|
Aggregate Intrinsic
Value |
|
| Balance Outstanding December 31, 2018 |
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
| Granted |
|
|
2,050,000 |
|
|
|
0.10 |
|
|
|
|
|
|
|
|
|
| Cancelled |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
| Balance Outstanding December 31, 2019 |
|
|
2,050,000 |
|
|
$ |
0.10 |
|
|
|
4.66 |
|
|
$ |
4,400 |
|
| Granted |
|
|
288,750 |
|
|
|
0.10 |
|
|
|
|
|
|
|
|
|
| Cancelled |
|
|
(288,750 |
) |
|
|
(0.10 |
) |
|
|
|
|
|
|
|
|
| Exercisable, December 31, 2020 |
|
|
2,050,000 |
|
|
$ |
0.05 |
|
|
|
3.66 |
|
|
$ |
137,000 |
|
|